Pedro Huertas

2020 - Inozyme Pharma

In 2020, Pedro Huertas earned a total compensation of $1.2M as Senior Vice President and Chief Medical Officer at Inozyme Pharma.

Compensation breakdown

Non-Equity Incentive Plan$159,137
Option Awards$604,993
Salary$397,843
Total$1,161,973

Huertas received $605K in option awards, accounting for 52% of the total pay in 2020.

Huertas also received $159.1K in non-equity incentive plan and $397.8K in salary.

Rankings

In 2020, Pedro Huertas' compensation ranked 7,996th out of 13,090 executives tracked by ExecPay. In other words, Huertas earned more than 38.9% of executives.

ClassificationRankingPercentile
All
7,996
out of 13,090
39th
Division
Manufacturing
3,392
out of 5,618
40th
Major group
Chemicals And Allied Products
1,372
out of 2,251
39th
Industry group
Drugs
1,194
out of 1,951
39th
Industry
Pharmaceutical Preparations
887
out of 1,456
39th
Source: SEC filing on April 27, 2021.

Huertas' colleagues

We found two more compensation records of executives who worked with Pedro Huertas at Inozyme Pharma in 2020.

2020

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2020

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

News

In-depth

You may also like